PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack, S; Ramjee, G; Kamali, A; Rees, H; Crook, AM; Gafos, M; Jentsch, U; Pool, R; Chisembele, M; Kapiga, S; +11 more... Mutemwa, R; Vallely, A; Palanee, T; Sookrajh, Y; Lacey, CJ; Darbyshire, J; Grosskurth, H; Profy, A; Nunn, A; Hayes, R; Weber, J; (2010) PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet, 376 (9749). pp. 1329-37. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(10)61086-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(10)61086-0

Abstract

Share

Download

Filename: main.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar